The safety of new oral anticoagulants for ischemic stroke and systemic embolism prevention in females with atrial fibrillation
The prevalence of atrial fibrillation is lower in females than in men, but the risk of stroke and systemic thromboembolism is comparable or even higher. Administration of anticoagulant therapy does not modify this difference. Two classes of non-vitamin K antagonist oral anticoagulants were studied i...
Main Authors: | Despina-Manuela Toader, Ileana Neaca, Alina Paraschiv, Rodica Musetescu |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2021-03-01
|
Series: | Romanian Journal of Neurology |
Subjects: | |
Online Access: | https://rjn.com.ro/articles/2021.1/RJN_2021_1_Art-01.pdf |
Similar Items
-
Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study
by: Maxim Grymonprez, et al.
Published: (2022-09-01) -
Atrial fibrillation and coronary artery disease: a review on the optimal use of oral anticoagulants
by: Pier Paolo Bocchino, et al.
Published: (2021-09-01) -
Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults – a systematic review of reviews and the development of recommendations to reduce inappropriate prescribing
by: Christina Sommerauer, et al.
Published: (2017-10-01) -
Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study
by: Maxim Grymonprez, et al.
Published: (2023-02-01) -
Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study
by: Emma Kirstine Laugesen, et al.
Published: (2019-11-01)